Skip to Content

Dawnrays Pharmaceutical (Holdings) Ltd 02348

Morningstar Rating
HKD 1.19 −0.01 (0.83%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

02348 is trading at a 42% premium.
Price
HKD 1.20
Fair Value
HKD 9.43
Uncertainty
Very High
1-Star Price
HKD 5.11
5-Star Price
HKD 4.18
Economic Moat
Ccvr
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 02348 is a good fit for your portfolio.

Trading Information

Previous Close Price
HKD 1.20
Day Range
HKD 1.181.20
52-Week Range
HKD 0.981.40
Bid/Ask
HKD 1.18 / HKD 1.30
Market Cap
HKD 1.79 Bil
Volume/Avg
32,000 / 281,171

Key Statistics

Price/Earnings (Normalized)
5.09
Price/Sales
1.42
Dividend Yield (Trailing)
7.33%
Dividend Yield (Forward)
7.33%
Total Yield
7.27%

Company Profile

Dawnrays Pharmaceutical (Holdings) Ltd is a drug manufacturing company. The company operates two segments, including Intermediates and Bulk Medicines, and Finished Drugs. The revenue is derived from the Finished Drugs segment. Nearly all of the company's sales are generated in Mainland China. It utilizes strategic partnerships as a component of its international strategies. The company is open to exploring potential acquisitions as a component of its overall growth plan.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
1,143

Comparables

Valuation

Metric
02348
02877
01672
Price/Earnings (Normalized)
5.096.64
Price/Book Value
0.570.920.56
Price/Sales
1.421.4223.67
Price/Cash Flow
5.166.25
Price/Earnings
02348
02877
01672

Financial Strength

Metric
02348
02877
01672
Quick Ratio
2.072.9716.51
Current Ratio
2.593.3516.58
Interest Coverage
1,084.97419.36−1,693.40
Quick Ratio
02348
02877
01672

Profitability

Metric
02348
02877
01672
Return on Assets (Normalized)
11.64%10.83%−5.34%
Return on Equity (Normalized)
15.46%13.16%−5.59%
Return on Invested Capital (Normalized)
14.62%12.66%−9.56%
Return on Assets
02348
02877
01672
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ADwbvlpqsSnt$79.4 Bil
MKKGY
Merck KGaA ADRMvxrwnjrqCglrbr$79.0 Bil
HLN
Haleon PLC ADRMbxmqzgTdqfh$38.5 Bil
VTRS
Viatris IncSgsjdzssLfx$13.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRVgxvvvbgCtr$11.6 Bil
CTLT
Catalent IncPhmfybylZyxfwq$10.0 Bil
CURLF
Curaleaf Holdings IncYxlmvnfcMzw$4.2 Bil
PRGO
Perrigo Co PLCVxjzslfKrvw$4.0 Bil
PBH
Prestige Consumer Healthcare IncKpdvsklnFylhz$3.2 Bil
GTBIF
Green Thumb Industries IncKssxpwkrjzKnty$3.1 Bil

Sponsor Center